MARKET

SOPH

SOPH

Sophia Genetics Sa
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.370
+0.130
+3.07%
Opening 09:47 08/18 EDT
OPEN
4.340
PREV CLOSE
4.240
HIGH
4.370
LOW
4.340
VOLUME
1.05K
TURNOVER
4.58K
52 WEEK HIGH
19.80
52 WEEK LOW
2.160
MARKET CAP
280.35M
P/E (TTM)
-3.4617
1D
5D
1M
3M
1Y
5Y
SOPHiA GENETICS (NASDAQ:SOPH shareholders incur further losses as stock declines 12% this week, taking one-year losses to 75%
SOPHiA GENETICS SA ( NASDAQ:SOPH ) shareholders will doubtless be very grateful to see the share price up 45% in the...
Simply Wall St. · 2d ago
BRIEF-Sophia Genetics SA Files For Mixed Shelf Of Up To $200 Mln
BRIEF-Sophia Genetics SA Files For Mixed Shelf Of Up To $200 Mln
Reuters · 08/09 21:53
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of 0% and 0.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/09 12:35
Sophia Genetics: Q2 Earnings Insights
  Sophia Genetics (NASDAQ:SOPH) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Benzinga · 08/09 12:18
BRIEF-Sophia Genetics Reports Financial Results For The Second Quarter Of Fiscal 2022
BRIEF-Sophia Genetics Reports Financial Results For The Second Quarter Of Fiscal 2022
Reuters · 08/09 11:48
SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
SOPHiA Genetics press release (<span class="ticker-hover-wrapp...
Seekingalpha · 08/09 11:23
Sophia Genetics Q2 EPS $(0.31) Beats $(0.39) Estimate, Sales $11.70M Miss $11.95M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.39) by 20.51 percent. This is unchanged from the same period last year. The company reported
Benzinga · 08/09 11:08
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
Steady Operational Performance Amidst Macroeconomic HeadwindsBOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results fo...
GlobeNewswire · 08/09 11:05
More
No Data
Learn about the latest financial forecast of SOPH. Analyze the recent business situations of Sophia Genetics Sa through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SOPH stock price target is 13.00 with a high estimate of 13.00 and a low estimate of 13.00.
High13.00
Average13.00
Low13.00
Current 4.370
EPS
Actual
Estimate
-0.31-0.23-0.16-0.08
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Institutional Holdings
Institutions: 27
Institutional Holdings: 20.47M
% Owned: 32.03%
Shares Outstanding: 64.15M
TypeInstitutionsShares
Increased
8
177.00K
New
6
3.22M
Decreased
10
237.02K
Sold Out
10
188.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Software
-0.47%
Software & IT Services
-0.30%
Key Executives
Non-Executive Chairman/Independent Director
Troy Cox
Chief Executive Officer/Co-Founder/Director
Jurgi Camblong
Chief Financial Officer
Ross Muken
Chief Human Resource Officer
Manuela Da Silva Valente
Chief Scientific Officer
Zhenyu Xu
Other
Philippe Menu
Other
Daan Van Well
Non-Executive Independent Director
Tomer Berkovitz
Non-Executive Independent Director
Kathy Hibbs
Non-Executive Independent Director
Didier Hirsch
Non-Executive Independent Director
Vincent Ossipow
Non-Executive Independent Director
Milton Silva-Craig
No Data
No Data
About SOPH
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Webull offers kinds of Sophia Genetics SA stock information, including NASDAQ:SOPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SOPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SOPH stock methods without spending real money on the virtual paper trading platform.